期刊文献+

人心肌肌钙蛋白I化学发光免疫分析方法的建立 被引量:2

Establishment of chemiluminescent immunoassay for determination of human cardiac troponin I (cTnI)
下载PDF
导出
摘要 目的 建立检测人心肌肌钙蛋白I(cTnI)化学发光免疫分析方法。方法 用重组cTnI免疫新西兰兔获得抗体 ,经DEAE 2 3层析和 (NH4) 2 SO4沉淀纯化后 ,用碳化二亚胺 (EDC)法标记辣根过氧化物酶 ,SephadexG 2 0 0纯化。优化鲁米诺 H2 O2 肉桂酸发光体系 ,建立了cTnI化学发光免疫分析法。用该法检测 138例正常人及病人血清标本 ,确定正常值参考范围 ,并与ELISA法比较。结果 所得抗体的滴度为 1∶80 0 0。优化后的发光体系为 :鲁米诺 (4 .5mmol/L) ,H2 O2 (7.5mmol/L) ,四苯硼钠 (0 .8mmol/L) ,肉桂酸 (0 .4mmol/L) ,比单独用肉桂酸或四苯硼钠作增强剂灵敏度分别增加了 1.19和 1.0 5倍。本法检测灵敏度为0 .2ng/ml,线性范围为 0 .4~ 5 0ng/ml,批内CV平均 9.0 % ,批间CV平均 11.8% ,回收率为 10 4 .2 %。Hb浓度在 0~ 5 0nmol/L ,T Bil在 0~ 15 μmol/L ,TG在 0~ 2 .0mmol/L对测定结果无影响。与ELISA比较 ,两法结果一致 (P >0 0 5 ) ,相关系数r=0 .985 2(P <0 .0 1)。用BioCheck标准品为校正物 ,确定临床诊断参考范围为 <2 .12ng/ml,诊断符合率为 96 .2 %。结论 建立的cTnI化学发光免疫分析法可常规用于临床检验。 Objective To establish a method of chemiluminescent immunoassay for determination of cTnI.Method Antibodies were produced by immunizing New Zealand rabbits with recombinant cTnI and were purified by DEAE-23 chromatography and (NH4)2SO4 centrifugation.Conjugation of horseradish peroxidase to immunoglobulin G was performed by EDC method and purified by Sephadex-G200 chromatography.Chemiluminescent immunoassay was established by optimizing luminol-H 2O 2-coumaric acid-NaTPB luminescent system.Sensitivity,linear scope,precision,interference,and recovery for the method were evaluated.The reference range was defined by testing 138 serum samples from healthy subjects and compared to the results determined by ELISA.Result The antibody titer of ELISA was 1∶8 000.The optimized luminescent system was as follows:luminol:(4.5 mmol/L),H 2O 2(7.5 mmol/L),NaTPB(0.8 mmol/L) and coumaric acid(0.4 mmol/L).The sensitivity of this method was 0.2ng/ml with 1.19 and 1.05-fold increase compared to using coumaric acid and NaTPB respectively.Linear scope was 0.4~50 ng/ml.Average intra-assay and inter-assay precision was 9.0% and 11.8% respectively.Average recovery was 104.2%. The concentrations (for hemoglobin:0~50mmol/L,total bilirubin:0~15 μmol/L,triglyceride:0~2.0 mmol/L) do not influence the testing result.Compared with ELISA,relative coefficient was 0.9852 (P> 0.05).The reference range for clinical diagnosis was less than 2.12 ng/ml by using Biocheck standard reference as rectifying sample.The coincident rate for diagnosis was 96.15%.Conclusion Successful establishment of chemiluminescent immunoassay method for cTnI paved a way for clinical application.
出处 《临床检验杂志》 CAS CSCD 北大核心 2004年第5期323-327,共5页 Chinese Journal of Clinical Laboratory Science
关键词 人心肌肌钙蛋白 化学发光免疫分析法 参考范围 抗体 肉桂酸 滴度 诊断符合率 鲁米诺 发光体系 定正 human cardiac troponin I chemiluminescent immunoassay experimental method
  • 相关文献

参考文献16

  • 1Ferrieres G, Calzolan C, Mani J C, et al. Human cardiac troponin Ⅰ precise identification of antigenic epitopes and prediction of secondary structure [ J ]. Clin Chem, 1998,44 ( 3 ) :487-493.
  • 2Anthony J M, Paul J R B. Close physical linkage of human troponin genes organization, sequence, and expression of the locus encoding cardiac troponin Ⅰ and slow skeletal troponin T[ J ]. Gene ,2000,242 :313-320.
  • 3Rost B, Sander C. Combining evolutionary information and neural networks to predict protein secondary structure[ J ]. Proteins, 1994,19( 1 ) :55-72.
  • 4Mogensen J, Kruse T A, Borglum A D. Assignment of the human cardiac troponin I gene (TNNI3) to chromosome 19q13. 4 by radiation hybrid mapping [ J ]. Cytogenet Cell Genet, 1997,79: 272-273.
  • 5Batron P I, Townsend P J, Brand N J, et al. Localization of the fast skeletal muscle troponin I gene ( TNNI2 ) to Ilp15. 5: genes for troponin I and T are organiszed in pairs[ J]. Ann Hum Genet, 1997,61 (6) :519-523.
  • 6Lane C, Calzolari C, Bertinchant J, et al. Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infaction[ J]. Clin Chem,1993 ,39 :972-979.
  • 7Apple F S, Henry T D, Berger C R, et al. Early monitoring of serum cardiac troponin I for assessment of coronary reperfusion following thrombolitic therapy [ J ]. Am J Clin Pathol, 1996,105 ( 1 ): 6-10.
  • 8Alain L, Guy H. Serum cardiac troponin I and T in early posttraumatic phabdomyolysis [ J]. Clin chem, 1998,4493:667-668.
  • 9靳彩宁,徐国宾,朱立华,夏铁安.人心肌TnI的生物学特性测定及其在临床诊断中的应用[J].临床检验杂志,2002,20(2):118-120. 被引量:87
  • 10潘柏申.心肌损伤标志物的研究进展与心肌梗死诊断标准的修订[J].临床检验杂志,2002,20(3):129-132. 被引量:137

二级参考文献79

  • 1[1]Wu A H B. Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins[J]. Scand J Clin Lab Invest,1999,59(Suppl 230): 74-82.
  • 2[2]Panteghni M, Apple F S, Christenson R H, et al. Proposal from IFCC committee on Standadization of Markers of Cardiac Damage (C-SMCD): recommendation on use of biochemical markers of cardiac damage in acute coronary syndromes [J]. Scand J Clin Lab Invest, 1999,59(Suppl 230): 103-112.
  • 3[3]Wu A H,Apple F S ,Gibler W B, et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery disease[J]. Clin Chem,1999,45: 1104-1121.
  • 4[4]Alpert J S, Thygesen K, Antman E, et al. Myocardial infarction redefined:a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction[J]. J Am Coll Cardiol, 2000,36: 959-969.
  • 5[5]Giri S,Waters D D,Wu A H B. Pathophysiology of acute coronary syndromes In: Card iac markers. Ed. Wu A H B. New Jersey:Humana Press Inc, 1998.21-44.
  • 6[6]Winter R J, Fischer J, Bholasingh R, et al. C-reactive protein and cardiac troponin T in risk stratification:differences in optimal timing of tests early after the onset of chest pain[J]. Clin Chem,2000,46:1597-1603.
  • 7[7]Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary, heart disease in initial healthy middle-aged men: results from the MONICA Augsburg Cohort Study, 1984 to 1992 [J]. Circulation, 1999, 99:237-242.
  • 8[8]Zimmerman J, Fromm R, Meyer D, et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction [J].Circulation, 1999,99: 1671-1677.
  • 9[9]Roberts W T, Sedrick R, Moulton L, et al. Evaluation of four automated high-sensitivity C-reactive protein methxts: implications for clinical and epidemiological applications[J]. Clin Chem, 2000,46:461-468.
  • 10[10]Rifai N, Ridker P M. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease [J]. Clin Chem,2001,47: 403-411.

共引文献229

同被引文献11

  • 1牛利茹,毕亚丽,李金伟.血标本溶血对检验结果的影响及防范对策[J].临床误诊误治,2005,18(9):691-692. 被引量:22
  • 2A lport JS, Thygesen K, Antman E, et al. Myocard infarction redefined- A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction[J]. J Am Coll Cardiol. 2000. 36(3 ): 959-969.
  • 3Thygesen K,Alport JS,White HD,et al. Universal definition of myocardial infarction[ J]. Eur Heart J, 2007, 28 (20): 2525-2538.
  • 4Vermeer HJ,Thomassen E, de jonge N. Automated processing of serum indices used for interference detection by the laboratory information system[ J]. Clin Chem, 2005, 51 ( 1 ) : 244-247.
  • 5Kwon H J, Eun JS, Ki OM. The influence of hemolysis, turbidity and icterus on the measurments of CK-MB, troponin I and myoglobin [ J ]. Clin Chem Lab Med. 2003. 41 (3) : 360-364.
  • 6Snyder JA, Rogers MW, King MS, et al. The impact of hemolysis on Ortho-Clinical Diagnostic's ECi and Roche's elecsys immunoassay systems[J]. Clin Chim Acta, 2004,348(1-2) : 181-187.
  • 7Giovanni B, Saveria C, Roberta DD, et al. The effect of sample hemolysis on cardiac troponin I and T assay[J]. Clin Chem, 2010, 56 (8) : 1357-1358.
  • 8周建光,杨梅,刘兆川.心肌损伤早期标志物的特性及及临床应用[J].当代医学:学术版,2008( 1):43.
  • 9Newby LK, Goldman Bu, ohman EM. Troponin: animportant prognostic maker and risk-stratification toolin non -ST -segment elevation acute coronarysyndromes J Am Coll Cardiol, 2003, 41(4):31-36.
  • 10潘柏申.心肌损伤标志物的研究进展与心肌梗死诊断标准的修订[J].临床检验杂志,2002,20(3):129-132. 被引量:137

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部